Analyst: AbbVie's acquisition of Shire will be good for Massachusetts
July 18, 2014 at 13:44 PM EDT
In the $54 billion acquisition of Shire by AbbVie, the latest of a string of megamergers in the biotech industry aimed at lowering taxes, at least one analyst sees Massachusetts as the big winner...
